Episode
Engineering Organs: The Science Powering Xenotransplantation
- Podcast
- Moving Medicine Forward
- Published
- Jun 11, 2026
- Duration seconds
- 1465
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/moving-medicine-forward-6832193/episodes/engineering-organs-the-science-powering-xenotransplantation/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/moving-medicine-forward-6832193/engineering-organs-the-science-powering-xenotransplantation.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
In this episode of Moving Medicine Forward , Dr. Robert Fisher—one of the pioneers of modern transplant surgery—explores the rapidly advancing field of xenotransplantation and why it may represent a true turning point in medicine. From CRISPR-driven genetic engineering to breakthroughs in immunosuppression and scalable organ production, Dr. Fisher breaks down how decades of research are converging to make cross-species organ transplants a clinical reality. The conversation also dives into what this means for patients, how it could transform transplant access, and the critical role of rigorous, collaborative clinical research in translating breakthrough science into real-world care. 01:23 Dr. Fisher’s path into transplant surgery 03:05 Why xenotransplantation is reaching a turning point (CRISPR + immunosuppression) 04:47 Advances enabling scalability, safety, and compatibility 08:32 Ethics, risks, and clearing misconceptions 10:27 Real-world patient impact and clinical considerations 13:10 Logistics, coordination, and clinical execution 15:49 New immunosuppression strategies driving success 17:44 Collaboration, ethics, and managing risk 20:49 Eliminating waitlists: expanding access to transplant 22:54 Milestones toward adoption and future outlook